L. Norregaard

Generation of an activating Zn2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle

T. Litman, U. Gether, C. Loland, 2002, Proceedings of the National Academy of Sciences of the United States of America.

The monoamine neurotransmitter transporters: structure, conformational changes and molecular gating.

U. Gether, L. Norregaard, 2001, Current opinion in drug discovery & development.

Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites.

H Weinstein, J. Ballesteros, H. Weinstein, 2000, Biochemistry.

Evidence for Distinct Sodium-, Dopamine-, and Cocaine-dependent Conformational Changes in Transmembrane Segments 7 and 8 of the Dopamine Transporter*

U. Gether, C. Loland, L. Norregaard, 2003, Journal of Biological Chemistry.

Zn2+ site engineering at the oligomeric interface of the dopamine transporter

J. Javitch, U. Gether, H. Hastrup, 2002, FEBS letters.

Development of selective antibodies against the human somatostatin receptor subtypes sst1-sst5.

C. Stidsen, L. Helboe, L. Norregaard, 1997, Brain research. Molecular brain research.

Delineation of an endogenous zinc‐binding site in the human dopamine transporter

E. Nielsen, U. Gether, L. Norregaard, 1998, The EMBO journal.

The Role of Zinc Ions in Reverse Transport Mediated by Monoamine Transporters*

H. Sitte, M. Freissmuth, U. Gether, 2002, The Journal of Biological Chemistry.

Quantification of intracellular metabolic fluxes from fractional enrichment and 13C-13C coupling constraints on the isotopomer distribution in labeled biomass components.

J Villadsen, K Schmidt, J. Villadsen, 1999, Metabolic engineering.

Defining Proximity Relationships in the Tertiary Structure of the Dopamine Transporter

U. Gether, C. Loland, U Gether, 1999, The Journal of Biological Chemistry.